S2Medical AB (S2M) - Total Liabilities

Latest as of December 2025: Skr7.03 Million SEK ≈ $756.25K USD

Based on the latest financial reports, S2Medical AB (S2M) has total liabilities worth Skr7.03 Million SEK (≈ $756.25K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See how liquid is S2Medical AB's working capital to evaluate short-term liquidity relative to the company's equity base.

S2Medical AB - Total Liabilities Trend (2015–2025)

This chart illustrates how S2Medical AB's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see S2M current and non-current assets.

S2Medical AB Competitors by Total Liabilities

The table below lists competitors of S2Medical AB ranked by their total liabilities.

Company Country Total Liabilities
IMMERSION G. S.A. ZY 10
F:73W
Germany €337.16K
Churchill China plc
LSE:CHH
UK GBX15.76 Million
Watkin Jones PLC
LSE:WJG
UK GBX165.03 Million
Faron Pharmaceuticals Oy
LSE:FARN
UK GBX32.45 Million
Craven House Capital PLC
LSE:CRV
UK $1.93 Million
Alkemy Capital Investments Plc
LSE:ALK
UK GBX4.76 Million
STMicroelectronics NV
LSE:0INB
UK €7.83 Billion
Aequus Pharmaceuticals Inc
V:AQS
Canada CA$7.09 Million

Liability Composition Analysis (2015–2025)

This chart breaks down S2Medical AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See S2M equity to assets ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.56 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.71 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.42 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how S2Medical AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for S2Medical AB (2015–2025)

The table below shows the annual total liabilities of S2Medical AB from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 Skr7.03 Million
≈ $756.25K
+11.78%
2024-12-31 Skr6.29 Million
≈ $676.58K
-68.17%
2023-12-31 Skr19.75 Million
≈ $2.13 Million
+8.36%
2022-12-31 Skr18.22 Million
≈ $1.96 Million
+21.54%
2021-12-31 Skr15.00 Million
≈ $1.61 Million
+76.90%
2020-12-31 Skr8.48 Million
≈ $912.24K
+51.40%
2019-12-31 Skr5.60 Million
≈ $602.53K
+1.21%
2018-12-31 Skr5.53 Million
≈ $595.34K
+45.66%
2017-12-31 Skr3.80 Million
≈ $408.73K
+3.35%
2016-12-31 Skr3.67 Million
≈ $395.49K
+6.24%
2015-12-31 Skr3.46 Million
≈ $372.24K
--

About S2Medical AB

ST:S2M Sweden Medical Instruments & Supplies
Market Cap
$483.55K
Skr4.49 Million SEK
Market Cap Rank
#31076 Global
#729 in Sweden
Share Price
Skr0.01
Change (1 day)
-3.85%
52-Week Range
Skr0.00 - Skr0.01
All Time High
Skr1000000.00
About

S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and… Read more